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‘Southdene Swgeuy, South Woodford and *Forest Surgery, Loughton, Essex, U.K. 
Epidemiological data suggest long term oxygen therapy (LTOT) delivered by oxygen concentrators in patients with 
severe hypoxic chronic obstructive pulmonary disease (COPD) is under-prescribed by General Practitioners (GPs) 
in England and Wales. One reason for this may be the unavailability to GPs of a measure of arterial oxygenation 
needed to fulfil the defined prescription criteria. Provision of a non-invasive measure of oxygenation may improve 
detection of hypoxic subjects and increase appropriate prescribing. 
This study aimed to evaluate pulse oximetry in a general practice setting and to screen for severe undetected 
hypoxaemia fulfilling the LTOT prescription criteria in patients with COPD. 
All COPD patients attending surgery in two practices were screened with oximeters for hypoxaemia. Those with 
an oxygen saturation of 592% were referred to hospital for formal arterial blood gas analysis and an oxygen 
concentrator assessment. GPs were asked to evaluate their experience in the ease of use and application of oximetry. 
The number of patients receiving oxygen by concentrator before the study was compared with the national rate and 
the number after the study with the estimated need suggested by epidemiological studies. 
Over a 12-month period a total of 114 patients were screened in the two practices with a combined list size of 
15 742. Thirteen patients had saturations of i 92%. Two refused and 11 underwent formal arterial gas analysis. 
Three had PaO, 17.3 kPa and new prescriptions for oxygen concentrators were made in these previously 
unsuspected severely hypoxaemic subjects as a result. One other hypoxaemic subject was referred and found to have 
another treatable medical condition. The initial prevalence of concentrator prescription (0.013% CI 0.003,0.047) was 
similar to the national rate (0.024%) and the prevalence observed after screening (0.031%, CI 0.013, 0.073) fell within 
the lower suggested prescription need of previous epidemiological data (0.02-0.10%). All practitioners found the 
oximeters simple to use and helpful in assisting with assessment of the severity of their patients’ condition. 
Oximetry provides a readily usable non-invasive method of screening and when applied to all COPD patients seen 
in general practice can reveal those fulfilling the criteria for long term oxygen who would otherwise not be identified 
as needing this treatment. 
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Introduction 
Oxygen therapy for domiciliary use in the management of 
chronic obstructive pulmonary disease (COPD) in England 
and Wales is prescribed as either long term oxygen therapy 
(LTOT) delivered via an oxygen concentrator to improve 
life expectancy or short burst oxygen via cylinders for 
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palliative relief of breathlessness. LTOT prescribed for 
home use and given for more than 15 h each day is proven 
to increase life expectancy in patients with COPD with 
severe hypoxia (1,2). This therapy is recommended in the 
Drugs Tariff (3) where specific criteria for its use are 
described. The patient must have spirometrically proven 
COPD with arterial PaO, ~7.3 kPa, with the subject having 
received full and appropriate bronchodilator therapy. Sta- 
tistics from the Department of Health (4) suggest a relative 
under-prescription of this mode of treatment compared 
with projected prescribing from epidemiological studies 
(5,6) and comparisons with continental neighbours (7). 
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In England and Wales oxygen concentrators can only be 
prescribed by General Practitioners who themselves are 
unlikely to have direct access to the arterial blood gas 
measurements needed before the strict prescribing criteria 
for LTOT are met. Recommendation for LTOT is usually 
from a hospital physician but is dependent upon appropri- 
ate referral from primary care. The difficulty in selecting 
such patients on clinical grounds alone may be a contrib- 
uting factor to the under-prescription of concentrators in 
England and Wales. The detection of cyanosis as a clinical 
sign is unreliable and difficult and a previous study in a 
specialist chest clinic revealed that reliance upon patient 
symptoms and clinical suspicion may be misleading as a 
guide to fulfilling the criteria for LTOT (8). 
We hypothesized that provision to General Practitioners 
of a simple non-invasive method of assessing oxygen with a 
pulse oximeter might detect previously unsuspected cases of 
severe hypoxaemia in a primary care practice population. 
This study received ethical approval from the committees 
of Redbridge and Waltham Forest and North Essex Health 
Authorities. 
Methods 
Two local general practices, Southdene, South Woodford, 
London, and Forest Surgery, Loughton, Essex, both within 
the referral area of Whipps Cross Hospital agreed to 
participate in a joint project over a 12-month period to 
assess the value of pulse oximetry in the detection of 
previously unsuspected severe hypoxaemia in subjects with 
COPD. 
The Southdene practice with three principals had a list 
size of 6800 at the start of the study. During the 12 months 
661 new registrations were made whilst 757 left the list. 
Forest surgery with four principals had 8942 registered 
patients with 981 new and 379 deleted registrations during 
the study year. Both are geographically suburban without 
areas of particular social deprivation. The study ran from 
October 1994 to September 1995. 
The Minolta pulseox- (Minolta, Osaka, Japan), cost 
c. &1850, was chosen for this study. It has the advantage of 
relatively light weight and portability and has been vali- 
dated as a screening tool for detection of hypoxaemia 
previously (8). The oximeter has a fairly simple set-up 
procedure. The machine is plugged into the mains, although 
a battery option is available, switched on and a visual light 
source on the finger probe allows the operator to position 
the lightwave sensor over the appropriate portion of the 
finger-nail bed. The oximeter display provides a measure of 
the signal strength, the pulse rate and the arterial oxygen 
saturation (SaO,). 
Oximetry recording was standardized as follows. All 
operators received a brief theory and practical training 
session in pulse oximetry. Each measurement was com- 
menced as the patient sat down for their consultation. A 
brief explanation was given by the GP. The finger probe 
was placed appropriately over the nail bed and the machine 
activated. A check for a strong pulse was made and the 
probe repositioned if necessary. The oxygen saturation was 
noted after a stable reading (+ 1%) was observed over a 
60-s period. The saturation result and the age and sex of the 
patient were recorded with the date on a research record 
sheet. Southdene practice was provided with two oximeters 
for three principals and Forest shared three between four 
principals. 
All patients with a clinical diagnosis of COPD attending 
surgery or who received a home visit within the last 12- 
month period of the study underwent pulse oximetry ad- 
ministered by one of the GPs or a practice nurse. The 
diagnosis of COPD was made on clinical grounds by indi- 
vidual practitioners but included at least a significant smok- 
ing history with symptoms of progressive breathlessness. 
All patients with an oxygen saturation of 592% were 
asked to return for a further check when recovered from 
their current illness if acutely unwell with an exacerbation 
of COPD. Those with a second confirmed low reading or 
those with an initial low reading who were clinically stable 
were referred to the hospital for formal arterial blood gas 
analysis and spirometry. This was performed in the medical 
day unit by medical staff in accordance with a protocol used 
to determine the optimum oxygen requirement for LTOT. 
Thus an initial arterial blood sample was taken from the 
radial or brachial artery using a heparinized syringe and 
analysed using the ABL 3 (Radiometer, Copenhagen, 
Denmark) blood gas machine. If the PaO, was above 
7.3 kPa no further tests were performed. If the PaO, was 
below this level further tests were undertaken inspiring 
oxygen delivered at 1 1 min- ‘) by nasal cannulae from an 
MC44 oxygen concentrator (De Vilbiss Healthcare, 
Heston, U.K.) increasing by 1 1 increments every 30 min 
(range usually 1-3 1 min - ‘) until a PaO, over 8 kPa was 
attained with the minimal increase in the PaO,. Spirometry 
was performed using a Vitalograph alpha spirometer 
(Vitalograph Buckingham, U.K.). The best FEV, and FVC 
readings were taken independently from three technically 
satisfactory forced expiratory manoeuvres. Patients who 
satisfied the criteria for LTOT were referred back to 
their GP with appropriate advice on flow rate, method of 
delivery and usage time. 
The prevalence of patients receiving oxygen for concen- 
trators at the beginning of the study was compared with 
national figures. The prescription prevalence at the comple- 
tion of screening was compared with the epidemiological 
estimates of need (5,6). 
Each principal was questioned at completion of the study 
about ease and acceptability of use of the oximeter, and 
possible future applications in a general practice setting. 
Results 
Data collected from the two practices has been combined to 
allow statistical analysis. Between practice comparisons 
were deemed to have insufficient statistical power. A total 
of 114 patients with COPD were screened during the year. 
Thirteen subjects had an SaO, 592% (range 81-91%, 
median 90%). Two refused further investigation and 11 
were referred to hospital for arterial blood gas estimation. 
Three patients fulfilled the criteria for LTOT and were 
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TABLE 1. Spirometric and arterial blood gas values, age and sex of subjects screened with SaO, 
s 92% 
Sex 
Age FEV, FVC SaO, PaO, PaCO, 
(years) FEV, (1) (% pred) FVC (1) (% pred) (%I @Pa) @Pa) 
F 65 0.37 17 1.33 52 89 8.03 5.84 
M 74 0.71 30 1.52 49 87 7.12 5.99 
M 66 1.55 74 2.17 80 92 9.83 4.76 
M 71 0.8 31 1.4 38 88 7.20 6.00 
M 74 0.6 25 1.43 34 91 8.49 547 
M 76 0.61 22 1.04 28 90 8.36 5.35 
M 60 0.58 21 1.54 43 92 8.94 5.30 
M 67 1.57 46 3.06 69 89 8.20 5.01 
M 59 0.49 14 1.55 36 86 6.86 628 
M 79 0.78 29 1.68 48 91 9.05 5.21 
M 64 1.09 37 2.40 62 92 9.33 4.83 
subsequently prescribed this treatment by their GPs on the 
advice of a hospital respiratory physician. Spirometric and 
arterial blood gas data on these 11 patients are given in 
Table 1. There were 10 males, the summary mean and 
standard deviation values for the data were as follows: age 
68.6 years (6.3), FEV, 0.801 (0.41), FEV, %pred 32% (16) 
FVC 1.741 (0.55) FVC %pred 50% (15) SaO, 90% (2), 
PaO, 8.32 kPa (0.91), PaCO, 5.46 kPa (0.41). One further 
patient with a low screening SaO, was referred to hospital 
and found to be suffering from bronchiolitis obliterans 
organizing pneumonia. 
The two practices had two patients with COPD receiving 
oxygen from concentrators prior to the study and five in all 
at completion. Comparison between the initial prevalence 
of concentrator prescriptions in the two practices (2: 15742) 
with Department of Health figures for 1995 (4,9) 
(12739:51439 000) gave a prevalence of 0.0127% (95% CI 
0.003%, 0.047%) locally compared with 0.024% for England 
and Wales overall. A similar comparison between the 
prevalence of patients receiving concentrator prescriptions 
at the end of the study (5: 163 18) compared with epidemio- 
logical estimates of the requirement for the population of 
England and Wales made in 1983 (5.6) (lo-50 000: 
49 634 000) produced local practice figures of 0.03064% (CI 
0,013%, 0.073%) compared with the range of national 
estimates of need of 0.02-O.lO%, i.e. falling within the lower 
end of this range. 
All principles found the oximeter easy to use and accept- 
able given the time constraints of the surgery consultation 
period. Principles commented however that to be of use the 
oximeter had to be in the consulting room. Searching other 
rooms for the equipment put unacceptable time pressure on 
the consultation period. All patients found the measure- 
ment acceptable with no adverse comments. Many patients 
thought the technology within the surgery impressive. 
When considering future applications in general practice 
participants felt that it would be useful in assessing severity 
of hypoxaemic in asthmatics, COPD, and heart failure 
patients, although reservations were expressed abut interpret- 
ation of data in complex scenarios. Financial cost of the 
equipment was thought to be high and a likely limiting 
factor in use even if sufficient application were found. 
Discussion 
This study indicates that COPD patients with unsuspected 
severe hypoxaemia may be prevalent in primary care and 
that screening oximetry offers one method of detecting 
patients who might benefit from LTOT. There are however a 
number of other factors to consider before such a policy 
could be recommended. The study itself has limitations. 
Although a population of over 15 500 was included in this 
research it represents but a tiny fraction of those within 
England and Wales and may not be representative. In par- 
ticular both practices are suburban and fairly affluent. They 
could not claim to represent inner city populations from 
which much previous epidemiological data has been col- 
lected. It is likely however that smoking rates and therefore 
prevalence of COPD and resultant hypoxaemia would be 
higher in inner city practices and the potential for detection 
of severe hypoxaemia even greater. The prevalence of con- 
centrator prescriptions locally was however statistically simi- 
lar to the overall figures of England and Wales which 
includes concentrators prescribed for all medical indications. 
The prevalence of prescriptions at the end of the study fell 
within the lower estimates from epidemiological studies but 
outside the highest estimates for concentrator need. Further- 
more, the numbers of subjects with severe hypoxaemia and 
LTOT requirement detected in this study are tiny and 
extrapolating conclusions from such a small group is poten- 
tially misleading. It is true to say however that in the prac- 
tices studied there were patients who might benefit from 
LTOT who were not receiving this treatment before the study 
but who are now as a result of screening with oximetry. 
The practicality of providing general practices with 
oximeters is a different issue. The cost is significant but 
cheaper oximeters than the Minolta are available from 
about &lOOO. Although GPs felt that one machine per con- 
sulting room was necessary to facilitate the logistics of the 
1268 C. M. ROBERTS ET AL. 
consultation there are other practical options. For example 
a single oximeter could be available to the practice nurse 
who could screen all patients attending a COPDlasthma 
clinic or selectively perform oximetry at the request of a GP. 
There are some practical issues around the setting in 
which oximetry is performed that might make this situation 
more advisable. Firstly some subjects with COPD lower 
their oxygen saturation simply on walking (10,ll) and this 
may take 1 or 2 min to recover. An oximetry reading taken 
at the beginning of a consultation for practical purposes of 
speed and convenience might overestimate the prevalence 
of resting hypoxaemia. Secondly an unreliable saturation 
figure may be produced if the pulse signal strength is poor. 
This may occur because of incorrect positioning of the 
finger probe or because the pulse is weak e.g. low output 
heart failure, vasoconstriction from cold, or for other 
technical reasons e.g. wearing of nail varnish, strongly 
pigmented skin (12). All of these situations require the 
operator to have sufficient time and experience to allow for 
these potential errors and to correct them. 
A further concern would be in the over-interpretation of 
oximetry in other clinical settings. For instance reliance on 
oximetry alone in assessing acute deterioration in subjects 
with COPD receiving oxygen is notoriously hazardous as 
CO, retention may be ignored in the presence of apparently 
satisfactory SaO,. Reliance on oximetry alone in the pre- 
scription of oxygen therapy to such patients is fraught with 
hazard. Oximetry may also be used as part of the assess- 
ment of other acute medical problems e.g. asthma or 
pneumonia but might lead to inappropriate management 
decisions if used out of context. Full training in the 
interpretation of oximetry would be necessary before 
general use of oximeters could be recommended. 
Spirometers were not available in either of these practices 
as was the case in most U.K. GP surgeries at the time of the 
study. Since the publication of the British Thoracic Society 
guidelines on the management of COPD (13) which encour- 
ages the use of spirometry in general practice this situation 
may soon change. Certainly spirometry is essential in 
confirming the diagnosis of COPD by measuring the pres- 
ence of airflow obstruction. It must also be recognised 
however that spirometry alone has a limited role in screen- 
ing for severe hypoxia in this patient group (14). An 
alternative approach would be to provide open access to 
oximetry for general practice patients but in a hospital 
setting within a department of respiratory medicine. Oxi- 
metry could then be combined with an open access spirom- 
etry service to confirm the COPD diagnosis and to assist in 
interpretation of data by specialist respiratory physicians. 
Some patients with COPD may feel the journey to hospital 
a daunting prospect however as illustrated by the two 
refusals in this study. 
In conclusion we found that patients with unsuspected 
severe hypoxaemia are present in the primary care practice 
population and can be detected using oximetry as a screen- 
ing tool. The equipment is simple to use but relatively 
expensive and may have limited overall application in 
general practice. The setting in which screening should take 
place requires further examination. Referral to a specialist 
respiratory unit for full assessment would still be advisable 
to allow confirmation of the recommended arterial blood 
gas criteria and to determine the oxygen flow rate advisable 
prior to prescription of LTOT. 
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